163 related articles for article (PubMed ID: 7049292)
21. Plasma tricyclic drug levels in amitriptyline-treated depressed patients.
Robinson DS; Cooper TB; Ravaris CL; Ives JO; Nies A; Bartlett D; Lamborn KR
Psychopharmacology (Berl); 1979 Jun; 63(3):223-31. PubMed ID: 113807
[TBL] [Abstract][Full Text] [Related]
22. Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment.
Tyrer P
J Affect Disord; 1984 Feb; 6(1):1-7. PubMed ID: 6231324
[TBL] [Abstract][Full Text] [Related]
23. A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
Mountjoy CQ; Roth M; Garside RF; Leitch IM
Br J Psychiatry; 1977 Nov; 131():486-92. PubMed ID: 338081
[TBL] [Abstract][Full Text] [Related]
24. A comparison of phenelzine and imipramine in depressed inpatients.
Davidson JR; McLeod MN; Turnbull CD; Miller RD
J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
[TBL] [Abstract][Full Text] [Related]
25. Depression after minor closed head injury: role of dexamethasone suppression test and antidepressants.
Saran AS
J Clin Psychiatry; 1985 Aug; 46(8):335-8. PubMed ID: 4019422
[TBL] [Abstract][Full Text] [Related]
26. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
[TBL] [Abstract][Full Text] [Related]
27. Antidepressants not effective in headache associated with minor closed head injury.
Saran A
Int J Psychiatry Med; 1988; 18(1):75-83. PubMed ID: 3294202
[TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacology of phenelzine.
Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
[TBL] [Abstract][Full Text] [Related]
29. Response of depressive symptoms to nortriptyline, phenelzine and placebo.
Georgotas A; McCue RE; Friedman E; Cooper TB
Br J Psychiatry; 1987 Jul; 151():102-6. PubMed ID: 3676606
[TBL] [Abstract][Full Text] [Related]
30. Effects of phenelzine and amitriptyline on depression [proceedings].
Paykel ES; Rowan PR; Parker RR
Psychopharmacol Bull; 1981 Jan; 17(1):104-6. PubMed ID: 7232635
[No Abstract] [Full Text] [Related]
31. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
[TBL] [Abstract][Full Text] [Related]
32. New studies confirm MAO inhibitors' efficacy in treating severe anxiety.
González ER
JAMA; 1981 May; 245(18):1799-801. PubMed ID: 7014934
[No Abstract] [Full Text] [Related]
33. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial.
Paykel ES; Hollyman JA; Freeling P; Sedgwick P
J Affect Disord; 1988; 14(1):83-95. PubMed ID: 2963054
[TBL] [Abstract][Full Text] [Related]
34. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
[TBL] [Abstract][Full Text] [Related]
35. A comparative double-blind trial of the new antidepressant caroxazone and amitriptyline.
Cecchini S; Petri P; Ardito R; Bareggi SR; Torriti A
J Int Med Res; 1978; 6(5):388-94. PubMed ID: 359383
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
37. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
Quitkin FM; Stewart JW; McGrath PJ; Liebowitz MR; Harrison WM; Tricamo E; Klein DF; Rabkin JG; Markowitz JS; Wager SG
Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
[TBL] [Abstract][Full Text] [Related]
38. Clinical predictors of response to antidepressants in elderly patients.
Georgotas A; McCue RE; Cooper T; Chang I; Mir P; Welkowitz J
Biol Psychiatry; 1987 Jun; 22(6):733-40. PubMed ID: 3297176
[TBL] [Abstract][Full Text] [Related]
39. A re-examination of the clinical effects of imipramine and amitriptyline in depressive illness.
Beaini AY; Hindmarch I; Snaith RP
J Affect Disord; 1980 Jun; 2(2):89-94. PubMed ID: 6448887
[TBL] [Abstract][Full Text] [Related]
40. Amitriptyline and hydroxylated metabolite plasma levels in depressed outpatients.
Robinson DS; Cooper TB; Howard D; Corcella J; Albright D
J Clin Psychopharmacol; 1985 Apr; 5(2):83-8. PubMed ID: 3988974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
